Global Argatroban Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Published by: GIR (GlobalInfoResearch)

Catalog: Pharmaceuticals

Publishing Date: Oct 2016

Single User License: USD 3480

Corporate Users License: USD 4680

Delivery time: 24 hours

Pages: 106

Tables and Figures: 146

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=1091[url]

Scope of the Report:

This report focuses on the Argatroban in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Pfizer

SANDOZ

GlaxoSmithKline

fresenius-kabi

Eagle Pharmaceuticals

Mitsubishi Tanabe Pharma

Teva Pharmaceutical Industries

WEST-WARD

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle East and Africa

Market Segment by Type, covers

Argatroban Powder

Argatroban Injection

Market Segment by Applications, can be divided into

Heparin-induced thrombocytopenia (HIT)

Percutaneous Coronary Intervention

Cerebral arterial thrombosis

There are 13 Chapters to deeply display the global Argatroban market.

Chapter 1, to describe Argatroban Introduction, product scope, market overview, market opportunities, market risk, market driving...